📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sustained Ex Vivo Susceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia. (2017)

First Author: Amambua-Ngwa A

Attributed to: Plasmodium Falciparum anti-malaria drug resistance in The Gambia: Identification of potential genetic markers by retrospective whole genome approaches funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.00759-17

PubMed Identifier: 28971859

Publication URI: http://europepmc.org/abstract/MED/28971859

Type: Journal Article/Review

Volume: 61

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 12

ISSN: 0066-4804